Restricted access

Research article

First published online December, 1994

Use of Safety-Modified Retroviruses to Introduce Chemotherapy Resistance Sequences into Normal Hematopoietic Cells for Chemoprotection During the Therapy of Ovarian Cancer: A Pilot Trial. M.D. Anderson Cancer Center,Houston,Texas